GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

Allowing such medications as options could lead to significant savings from improved health, writes Kelley Koch.

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

President Trump established by way of executive order a Make America Healthy Again Commission. However, much of what’s ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Levy leads a team of about 40 physicians in the adult cardiology program at Memorial Healthcare System in southern Broward ...

Cardiovascular diseases claim more lives in the U.S. than all forms of cancer and accidental deaths combined, according to ...

More than 36 million Americans have type 2 diabetes, a condition primarily attributed to the body's cells not responding to ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

Health experts recommend reducing a person's intake of ultra-processed foods. A registered dietitian and the CEO of Nourish ...